GLP-1 Drugs Could Impact Restaurant Demand in 2026 -- Market Talk

Dow Jones01-15

1537 ET - GLP-1 medications haven't seemed to make a dent on restaurant demand so far, but that could change as the drugs become cheaper and more widely accessible, Bank of America analysts write in a note. GLP-1 use has been concentrated among older and more affluent consumers that also tend to be the biggest spenders. "That said, the wider appeal and lower costs of recently introduced pills could tilt the balance," the analysts write, projecting that the impact could be most significant for quick-service restaurants. So far, the only restaurant company to report a demand effect from GLP-1s has been Darden Restaurants, they write. (elias.schisgall@wsj.com)

 

(END) Dow Jones Newswires

January 14, 2026 15:37 ET (20:37 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment